Ukraine to de-regulate national pharmaceutical market

1 June 2016
ukraine-big

The government of Ukraine is completing preparations for the de-regulation of the national pharmaceutical market, which involves easing access of Western drug imports to the market.

This is expected to be achieved through the adoption of the new law and other legislative acts in this field, reports The Pharma Letter’s local correspondent.

At the same time, according to Ukraine’s Prime Minister Vladimir Groisman, the attempts of the government to lobby for the adoption of the law that will ease access of foreign pharmaceutical drugs to the Ukrainian pharmaceutical market without certification are faced with serious opposition and resistance mainly from local drugmakers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical